|
|
 |
| |
|
Home > Drug Companies > Gilead Sciences, Inc.
Gilead Sciences, Inc.
Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life threatening diseases worldwide.
Gilead, with nearly 1,900 employees, has operations in North America, Europe and Australia. In North America, corporate headquarters are based in Foster City, California, with additional operations in San Dimas, California Durham, North Carolina and Toronto, Canada. European operations are based in Uxbridge, United Kingdom and Dublin, Ireland. Additionally, sales and marketing organizations are located in the following cities: Athens, Greece Cambridge, United Kingdom Lisbon, Portugal Madrid, Spain Melbourne, Australia Milan, Italy Munich, Germany and Paris, France.
Gilead takes great pride in its unique portfolio of therapeutics, designed to advance the care of patients suffering from life threatening infectious diseases. Currently, their portfolio includes eight marketed products. From their inception, the people of Gilead across North America, Europe, and Australia have shared a vision of advancing therapeutics for life threatening diseases worldwide.
As a leading biopharmaceutical company, they have been fulfilling that vision for more than a decade discovering, developing and commercializing small molecule therapeutics to advance the care of patients suffering from life threatening infectious diseases. In addition to their marketed products, Gilead has a clinical, preclinical and research pipeline focused on developing anti infective. They take great pride in their portfolio of unique therapeutics, which includes a number of category firsts and market leaders.
The evolution of Gilead and their track record of success is testament to what the company has achieved through disciplined science, visionary thinking and diversified planning.
Back to Drug Companies
|
|
|
|
|
|
|
|